Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Paul Duic"'
Autor:
Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Julius Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward McClay, Louis Burt Nabors, Michael Salacz, Lynn Taylor, Brian Vaillant, Jaya Gill, Santosh Kesari
Publikováno v:
CNS Oncology, Vol 12, Iss 3 (2023)
Aim: The EMulate Therapeutics Voyager™ is a simple, wearable, home-use device that uses an alternating electromagnetic field to alter biologic signaling within cells. Objective: To assess the safety/feasibility of the Voyager in the treatment of re
Externí odkaz:
https://doaj.org/article/0926388dd46840d7b67cdd3a03d7b358
Autor:
Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/b6f8c241b60643f08e07c8c49fbc0fec
Autor:
Justin Leu, Meredith Akerman, Christopher Mendez, Jonathan W. Lischalk, Todd Carpenter, David Ebling, Jonathan A. Haas, Matthew Witten, Marissa Barbaro, Paul Duic, Lee Tessler, Michael C. Repka
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionBrain metastases are the most common intracranial tumor diagnosed in adults. In patients treated with stereotactic radiosurgery, the incidence of post-treatment radionecrosis appears to be rising, which has been attributed to improved pat
Externí odkaz:
https://doaj.org/article/3320c9ff6e714a2ea7a7c7e5157bd4e3
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Autor:
Charles Cobbs, Edward McClay, J Paul Duic, L Burt Nabors, Donna Morgan Murray, Santosh Kesari
Publikováno v:
CNS Oncology, Vol 8, Iss 1 (2019)
Aim: Evaluation of the Nativis Voyager® device in patients with recurrent glioblastoma (rGBM). Materials & methods: Voyager is a noninvasive, nonthermal, nonionizing and portable investigational device which delivers ultra-low radio frequency energy
Externí odkaz:
https://doaj.org/article/fa3e4c93c1534b618bb11c7cceb3aec3
Autor:
John H. Sampson, Thomas A. Davis, Tibor Keler, Christopher D. Turner, Michael J. Yellin, Jennifer A. Green, Yi He, Laura Vitale, Scott Cruickshank, Maciej M. Mrugala, J. Paul Duic, Lynn S. Ashby, Rimas V. Lukas, Daniela A. Bota, Gordon Li, Louis B. Nabors, Karen L. Fink, David D. Tran, Donald M. O'Rourke, James J. Vredenburgh, Annick Desjardins, David A. Reardon
Figure A3 from Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e5523b850e66966a71fc3a40a27da45
https://doi.org/10.1158/1078-0432.22473939
https://doi.org/10.1158/1078-0432.22473939
Autor:
Howard A. Fine, Paul S. Albert, Donald Thornton, Luna Musib, Jennifer Walling, Svetlana Kotliarova, Paul Duic, Kraig Moore, Lyndon Kim, Teri N. Kreisl
Purpose: Enzastaurin is a selective inhibitor of protein kinase C β. Prior phase I studies did not show increased drug exposures with escalating once daily administration. Limits from gastrointestinal absorption may be overcome by twice daily dosing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ba66e5356279b08adfdf4e1a9ed74d9
https://doi.org/10.1158/1078-0432.c.6516834.v1
https://doi.org/10.1158/1078-0432.c.6516834.v1
Autor:
John H. Sampson, Thomas A. Davis, Tibor Keler, Christopher D. Turner, Michael J. Yellin, Jennifer A. Green, Yi He, Laura Vitale, Scott Cruickshank, Maciej M. Mrugala, J. Paul Duic, Lynn S. Ashby, Rimas V. Lukas, Daniela A. Bota, Gordon Li, Louis B. Nabors, Karen L. Fink, David D. Tran, Donald M. O'Rourke, James J. Vredenburgh, Annick Desjardins, David A. Reardon
Web Extra Material - 2 tables and 3 figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f78b399144b94b4e4ba8ee0ccc969b4
https://doi.org/10.1158/1078-0432.22473936.v1
https://doi.org/10.1158/1078-0432.22473936.v1
Autor:
John H. Sampson, Thomas A. Davis, Tibor Keler, Christopher D. Turner, Michael J. Yellin, Jennifer A. Green, Yi He, Laura Vitale, Scott Cruickshank, Maciej M. Mrugala, J. Paul Duic, Lynn S. Ashby, Rimas V. Lukas, Daniela A. Bota, Gordon Li, Louis B. Nabors, Karen L. Fink, David D. Tran, Donald M. O'Rourke, James J. Vredenburgh, Annick Desjardins, David A. Reardon
Purpose:Rindopepimut is a vaccine targeting the tumor-specific EGF driver mutation, EGFRvIII. The ReACT study investigated whether the addition of rindopepimut to standard bevacizumab improved outcome for patients with relapsed, EGFRvIII-positive gli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1db99d990206b480a8975605cdc812ac
https://doi.org/10.1158/1078-0432.c.6528645.v1
https://doi.org/10.1158/1078-0432.c.6528645.v1
Autor:
Howard A. Fine, Paul S. Albert, Donald Thornton, Luna Musib, Jennifer Walling, Svetlana Kotliarova, Paul Duic, Kraig Moore, Lyndon Kim, Teri N. Kreisl
Supplementary Data from A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c59f4e7215f8bdd11cdb99ee355a3ab
https://doi.org/10.1158/1078-0432.22439349.v1
https://doi.org/10.1158/1078-0432.22439349.v1